Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain NVTR message board posts where the ticker symbol NVTR has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

Related news from
Mon, 24 Sep 2018
12:36:12 +0000
Implied Volatility Surging for Nuvectra (NVTR) Stock Options
Investors need to pay close attention to Nuvectra (NVTR) stock based on the movements in the options market lately.
Wed, 19 Sep 2018
18:06:57 +0000
What You Must Know About Nuvectra Corporation’s (NASDAQ:NVTR) Financial Strength
While small-cap stocks, such as Nuvectra Corporation (NASDAQ:NVTR) with its market cap of US$376.5m, are popular for their explosive growth, investors should also be aware of their balance sheet toRead More...
Fri, 14 Sep 2018
16:00:00 +0000
Nuvectra® Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nuvectra Corporation (NVTR), a neurostimulation medical device company, announced today the closing of its underwritten follow-on public offering of 3,248,750 shares of its common stock at a price to the public of $21.25 per share, which included the exercise in full by the underwriters of their option to purchase 423,750 additional shares of common stock on the same terms and conditions. Nuvectra intends to use the net proceeds from this offering to fund the expansion of product development and commercialization activities, as well as for general corporate purposes. Piper Jaffray served as the sole book-running manager for the offering.
Wed, 12 Sep 2018
02:09:53 +0000
Nuvectra® Announces Pricing of Follow-On Stock Offering
Nuvectra Corporation (NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares of its common stock at a price to the public of $21.25 per share. The offering is expected to close on or about September 14, 2018, subject to customary closing conditions. In addition, Nuvectra has granted the underwriters a 30-day option to purchase up to 423,750 additional shares of common stock on the same terms and conditions.
Tue, 11 Sep 2018
20:01:00 +0000
Nuvectra® Announces Proposed Follow-On Stock Offering
Nuvectra Corporation (NVTR), a neurostimulation medical device company, announced today that it is commencing an underwritten follow-on public offering of its common stock. Nuvectra intends to use the net proceeds from this offering to fund the expansion of product development and commercialization activities, as well as for general corporate purposes. Piper Jaffray is acting as sole book-running manager for the offering.
Wed, 05 Sep 2018
20:01:00 +0000
Nuvectra to Participate in Two Upcoming Investor Conferences
PLANO, Texas, Sept. 05, 2018-- Nuvectra Corporation, a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief ...
Tue, 21 Aug 2018
05:39:58 +0000
Edited Transcript of NVTR earnings conference call or presentation 7-Aug-18 8:30pm GMT
Q2 2018 Nuvectra Corp Earnings Call
Tue, 07 Aug 2018
22:00:10 +0000
Nuvectra (NVTR) Reports Q2 Loss, Tops Revenue Estimates
Nuvectra (NVTR) delivered earnings and revenue surprises of 9.78% and 13.63%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Tue, 07 Aug 2018
20:53:41 +0000
Nuvectra: 2Q Earnings Snapshot
The Plano, Texas-based company said it had a loss of 83 cents per share. The medical device company posted revenue of $13.1 million in the period. Nuvectra shares have risen 98 percent since the beginning ...
Tue, 07 Aug 2018
20:01:00 +0000
Nuvectra™ Reports Second Quarter 2018 Financial Results
PLANO, Texas, Aug. 07, 2018-- Nuvectra Corporation, a neurostimulation medical device company, announced today financial results for the second quarter ended June 30, 2018.. Reported record consolidated ...
Thu, 02 Aug 2018
20:01:00 +0000
Nuvectra™ Appoints Neuromodulation Veteran Ben Tranchina as Chief Technology Officer
Nuvectra Corporation (NVTR), a neurostimulation medical device company, announced today the appointment of Ben Tranchina as Chief Technology Officer (CTO), effective August 24, 2018. Mr. Tranchina has over 25 years of industry experience and most relevantly served as VP, Product Development at St. Jude Medical, where he led the development of the company’s neuromodulation portfolio, following his time at Advanced Neuromodulation Systems, Inc. Mr. Tranchina will replace the Company’s current CTO, Dr. Norbert Kaula, who announced his intention to resign to pursue other interests, effective August 17, 2018.
Tue, 31 Jul 2018
20:01:00 +0000
Nuvectra™ to Report Second Quarter 2018 Financial Results on August 7, 2018
PLANO, Texas, July 31, 2018-- Nuvectra Corporation, a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended June 30, 2018 on Tuesday, ...
Wed, 09 May 2018
03:46:13 +0000
Edited Transcript of NVTR earnings conference call or presentation 2-May-18 8:30pm GMT
Q1 2018 Nuvectra Corp Earnings Call



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is a great group of very smart, sophisticated investors. We have several professionals on board managing millions of dollars, and "average Joe" investors that beat the pants off of Wall Street professionals year in and year out. ValueForum will expose you to a wealth of ideas and sectors, and keep you ahead of the curve." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards